Showing results (71-80 of 582) with videos related to
Sort By:
Pageof 59
Microorganisms|April 3, 2021
Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus InhibitorsLana Langendries, Rana Abdelnabi, Johan Neyts, et al.Biochemical Pharmacology|September 6, 2011
Combating enterovirus replication: state-of-the-art on antiviral researchHendrik Jan Thibaut, Armando M De Palma, Johan NeytsJournal of Medical Virology|December 26, 2003
Inhibition of coxsackie B3 virus induced myocarditis in mice by 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrileElizaveta Padalko, Erik Verbeken, Erik De Clercq, et al.Journal of Virology|January 15, 2005
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenasePieter Leyssen, Jan Balzarini, Erik De Clercq, et al.Antiviral Research|July 6, 2013
The potential of antiviral agents to control classical swine fever: a modelling studyJantien A Backer, Robert Vrancken, Johan Neyts, et al.Reviews in Medical Virology|October 30, 2007
Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the futureGeoffrey Férir, Suzanne Kaptein, Johan Neyts, et al.Viruses|October 14, 2011
Antiviral treatment of chronic hepatitis B virus (HBV) infectionsErik De Clercq, Geoffrey Férir, Suzanne Kaptein, et al.Antiviral Research|August 24, 2004
Rodent models for the study of therapy against flavivirus infectionsNathalie Charlier, Pieter Leyssen, Erik De Clercq, et al.Antimicrobial Agents and Chemotherapy|May 25, 2004
Efficacy of cidofovir in a murine model of disseminated progressive vacciniaJohan Neyts, Pieter Leyssen, Erik Verbeken, et al.Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activityGerhard Puerstinger, Jan Paeshuyse, Erik De Clercq, et al.Pageof 59